EMEA-002165-PIP02-18 - paediatric investigation plan
(R)-azasetron (besilate) (SENS-401)
PIPHuman
Sensorion SA
E-mail: contact@sensorion-pharma.com
Tel. +33 4672 07730
P/0105/2019: EMA decision of 22 March 2019 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver for (R)-azasetron (besylate) (SENS-401) (EMEA-002165-PIP02-18)